Novel combinations of synthesized ZnO NPs and Ceftazidime: evaluation of their activity against standards and new clinically isolated pseudomonas aeruginosa
AJMB-Avicenna Journal of Medical Biotechnology. 2016; 8 (4): 169-174
en Inglés
| IMEMR
| ID: emr-185091
ABSTRACT
Background:
Antibiotic resistant bacteria can be considered as a main problem in infection management. Zinc oxide nanoparticles [ZnO NPs], individually or in combination with antibiotics, can be considered as good candidates for struggling against drug resistant bacteria
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Guía de Práctica Clínica
Idioma:
Inglés
Revista:
Avicenna J. Med. Biotechnol.
Año:
2016
Similares
MEDLINE
...
LILACS
LIS